Table 4.

Response of visual function parameters to rituximab and bortezomib combination therapy versus rituximab monotherapy.

	Rituximab monotherapy	Rituximab + Borzomib	Superiority of treatment
BCVA	6/6	6/6	R = R + B
HVF MD	4/6	5/6	R = R + b
HVF PSD	5/6	5/6	R = R + B
Scotopic B-wave	2/4	4/6	R $>$ R + b
Combined A-wave	4/4	2/6	R $<$ R + B
Combined B-wave	4/4	2/6	R $<$ R + B
30-Hz Amplitude	3/6	2/6	R = R + B
30-Hz Implicit time	6/6	6/6	R = R + B
BCVA, best-corrected visual acuity; B, bortezomib; HVF, Humphrey visual field; MD, mean deviation; Pattern standard deviation; R, rituximab